Equity Analysis

Score Board

    Kabra Drugs Ltd
    Industry :  Pharmaceuticals - Indian - Formulations
    BSE Code
    ISIN Demat
    Book Value()
    524322
    INE323K01017
    -2.2457859
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    N.A
    0
    3.16
    EPS(TTM)
    Face Value()
    Div & Yield %:
    0
    10
    0
     
As on: May 02, 2024 04:40 AM
Particulars
Company Name Kabra Drugs Ltd
Face Value 10
BSE Code 524322
Year End 202303
Full Year
Equity ( in Cr.) 4.39
B.V. -2.20
Sales in Cr. 0.00
NP in Cr. -0.34
NP Var% -82.00
Div% 0.00
CPS -0.80
EPS -0.80
Traded Value( in Lakhs) 0.27
52 Week High 7.00
52 Week Low 3.00
Price BSE 7.00
Price NSE 0.00
Market Capital( in Cr.) 3.16
P/C Ratio -9.10
P/E Ratio -9.10
Price Vs.BV -3.18
Latest Quarter
Year End 202312
Sales in Cr. 0.00
NP in Cr. -0.11
NP Var % -80.00
Trailing Twelve Months
Year End 202312
Sales 0.00
OPM 0.00
NP -0.23
NP Var% -102.11
EPS 0.00
PE 0.00